Jpmorgan Chase & CO Inogen Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Inogen Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 896,106 shares of INGN stock, worth $8.41 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
896,106
Previous 872,215
2.74%
Holding current value
$8.41 Million
Previous $7.09 Million
22.58%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding INGN
# of Institutions
143Shares Held
21MCall Options Held
119KPut Options Held
149K-
Camber Capital Management LP Boston, MA2MShares$18.8 Million0.62% of portfolio
-
Black Rock Inc. New York, NY1.63MShares$15.3 Million0.0% of portfolio
-
Brown Capital Management LLC Baltimore, MD1.56MShares$14.6 Million0.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.5MShares$14.1 Million0.0% of portfolio
-
Divisadero Street Capital Management, LP Miami, FL1.06MShares$9.91 Million1.38% of portfolio
About Inogen Inc
- Ticker INGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 22,866,500
- Market Cap $214M
- Description
- Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respirat...